The Psychedelic Drug Development Pipeline: Bullseye Chart Year-End 2023
BULLSEYE CHART
The Psychedelic Drug Development Pipeline
In early 2023, we visualised our Psychedelics Drug Development Tracker data in a ‘bullseye chart’ format as part of 2022’sĀ Year in Review. Due to its popularity, Noah Smith and Michael Haichin have once again prepared a bullseye chart of the psychedelic drug development pipeline, as it stood at the end of 2023.
Given the number of candidates included, we recommend downloading a PDF of the tracker for a better viewing experience. More info below the image.
Download a PDF Copy of the Chart
If you would like to receive a high-resolution PDF of the bullseye chart, please enter your email below. You may also opt-in to our newsletter by checking the box.
Stay Informed in 2024 with PĪ±+
This resource, which is part of our 2023 Year in Review, is free to access. Subscribe to PĪ±+Ā to receive all of our Bulletins, deep dives and analysis, as well as access to the PĪ±+ Library and other subscriber-only content.
Your subscription goes directly toward supporting our coverage, not glossy graphic design or marketing budgets. Learn more and subscribe here, or get in touch to discuss team plans.
Join thousands of psychedelics insiders
Get the weekly psychedelic medicine briefing.
A free weekly digest covering trials, regulation, policy, and access.
By signing up, you agree to our privacy policy. You can unsubscribe at any time.